BackQSAM Biosciences Overview

QSAM Biosciences Long Term Debt

Track QSAM Biosciences's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

QSAM Biosciences Long Term Debt History

Loading

QSAM Biosciences vs. peers: Long Term Debt Comparison

Loading

QSAM Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

QSAM Biosciences (QSAM) FAQ

As of the most recent data (December 2023), QSAM shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QSAM's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether QSAM Biosciences is outperforming or lagging.

Tracking QSAM's long-term debt over time shows whether QSAM Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has QSAM Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

QSAM Biosciences's long-term debt is $0; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.